Lara M C, de la Fuente J R
Instituto Mexicano de Psiquiatría, Mexico, DF.
Bol Oficina Sanit Panam. 1990 May-Jun;108(5-6):439-44.
To what extent can or should a patient influence medical decisions? For a valid decision to be made, it is usually considered essential that the patient be autonomous and competent. If a person is not incapacitated for autonomous action, he can accept or reject a medical intervention on the basis of the information available to him. This raises the question of what the patient is to be told. The answer rests on which value is considered fundamental in medical practice: the patient's well-being or respect for his status as a person. This controversy arises in both the strictly therapeutic and the research contexts. In both cases, information must be explicit and clear. Many printed forms are hard to understand; the patient's signature merely precludes the possibility of legal problems. Depending on the kind of disease and treatment, the patient's consent may at times be almost tacit while at other times it should be based on complete information, especially if his decision seems irrational or contrary to the physician's judgment. In clinical trials, information and consent problems usually relate to the possibility that information given the participant will invalidate the findings. Nevertheless, the patient's rights and well-being should always be considered more important than the research.
患者能够或应该在多大程度上影响医疗决策?为了做出有效的决策,通常认为患者具备自主性和行为能力至关重要。如果一个人没有丧失自主行动的能力,他可以根据自己所掌握的信息接受或拒绝医疗干预。这就引出了应该告知患者哪些信息的问题。答案取决于在医疗实践中哪种价值观被视为基本价值观:患者的福祉还是对其人格地位的尊重。这种争议在严格的治疗情境和研究情境中都会出现。在这两种情况下,信息都必须清晰明确。许多印刷表格难以理解;患者签字仅仅是为了避免法律问题。根据疾病和治疗的类型,患者的同意有时可能几乎是默许的,而在其他时候则应该基于完整的信息,特别是当他的决定似乎不合理或与医生的判断相悖时。在临床试验中,信息和同意问题通常涉及向参与者提供的信息可能使研究结果无效的可能性。然而,患者的权利和福祉应该始终被视为比研究更重要。